Before we begin our formal remarks, I want to take a moment to recognize Michael Bailen on his promotion to Vice President of ...
The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback